Cell MedX Corp (OTCMKTS:CMXC)’s share price fell 2.9% during trading on Tuesday . The stock traded as low as $0.31 and last traded at $0.33, 58,278 shares were traded during trading. A decline of 9% from the average session volume of 64,128 shares. The stock had previously closed at $0.34.
The stock has a 50 day moving average price of $0.50 and a two-hundred day moving average price of $0.41.
Cell MedX Company Profile (OTCMKTS:CMXC)
Cell MedX Corp., a development stage company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, and high blood pressure. It also develops and manufactures eBalance technology that is in the research and development stage to manage diabetes mellitus and its complications.
Featured Article: What is a support level?
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.